When we talk about GLP-1 medications, we’re usually focused on weight loss or the drug’s side effects (we’re looking at you, ...

Medical researchers have found that people who take the semaglutide-based drugs Ozempic and Wegovy may be less likely to die ...

A new study suggests semaglutide drugs like Ozempic, used for type 2 diabetes, may lower the risk of opioid overdose in ...

From alcoholism to Parkinson’s, scientists are studying the mechanisms behind the broad clinical potential of weight-loss ...

Semaglutide was linked to a significantly lower risk of overdose than other antidiabetic drugs in patients with type 2 ...

The Senate HELP Committee held a hearing to address the high cost of semaglutide drugs, finding that many patients cannot ...

Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established ...

The results suggest Ozempic could potentially become a new alternative treatment for opioid use disorder, which could help ...

A study of people with type 2 diabetes and opioid use disorder suggests that the key ingredient in Ozempic and Wegovy shows promise against addiction.

Semaglutide, the underlying drug marketed as Ozempic and Wegovy, works by mimicking a hormone that triggers the body to feel ...

Especially about the new generation of semaglutide-based injectable weight loss drugs such as Ozempic and Wegovy. These two weight loss drugs have been prescribed by doctors in the West to ...

Mineralocorticoid receptor antagonists (MRA) should be considered for all patients with heart failure, say researchers.